FORBIUS

Forbius (Formation Biologics) is a clinical-stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. The company is developing agents targeting the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways, enabling doctors to have highly active inhibitors of validated pathways that have a differentiated mechanism of action. Forbius’ medicines are designed to radically transform patients’ lives. Their strength is utilizing their knowledge of biology and diverse protein engineering technologies to design superior inhibitors of validated biological pathways. Forbius was founded in 2011 as a management-led spin-out from YM BioSciences, prior to YM's acquisition by Gilead.

#People #Financial #Website #More

FORBIUS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2011-01-01

Address:

Austin, Texas, United States

Country:

United States

Website Url:

http://www.forbius.com

Total Employee:

11+

Status:

Active

Contact:

(164) 725-5133

Email Addresses:

[email protected]

Total Funding:

21.98 M USD

Technology used in webpage:

SPF US Privacy User Signal Mechanism WordPress 6.0 Twemoji DMARC KnowBe4 DreamHost Hosting Dreamhost DNS Cisco Ironport Cloud Dmarcian

Current Advisors List

walter-blättler_image

Walter Blättler Board Of Directors @ Forbius
Board_member

anthony-tolcher_image

Anthony Tolcher Board of directors @ Forbius
Board_member

Current Employees Featured

steve-ledbetter_image

Steve Ledbetter
Steve Ledbetter Chief Development Officer @ Forbius
Chief Development Officer

paul-nadler_image

Paul Nadler
Paul Nadler Chief Medical Officer @ Forbius
Chief Medical Officer

gilles-tremblay_image

Gilles Tremblay
Gilles Tremblay Director Preclinical Development @ Forbius
Director Preclinical Development
2017-01-01

ilia-a-tikhomirov_image

Ilia A. Tikhomirov
Ilia A. Tikhomirov Founder, CEO, President & Board Member @ Forbius
Founder, CEO, President & Board Member
2011-04-01

maureen-oconnor-mccourt_image

Maureen O’Connor McCourt
Maureen O’Connor McCourt Chief Scientific Officer @ Forbius
Chief Scientific Officer

Founder

ilia-a-tikhomirov_image

Ilia A. Tikhomirov

Investors List

hbm-partners_image

HBM Partners

HBM Partners investment in Series C - Forbius

cancer-prevention-and-research-institute-of-texas_image

Cancer Prevention and Research Institute of Texas

Cancer Prevention and Research Institute of Texas investment in Grant - Forbius

biocanrx_image

BioCanRx

BioCanRx investment in Grant - Forbius

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series B - Forbius

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series B - Forbius

rosseau-asset-management_image

Rosseau Asset Management

Rosseau Asset Management investment in Venture Round - Forbius

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Venture Round - Forbius

mars-investment-accelerator-fund_image

MaRS Investment Accelerator Fund

MaRS Investment Accelerator Fund investment in Venture Round - Forbius

mars-innovation-mi_image

Toronto Innovation Acceleration Partners

Toronto Innovation Acceleration Partners investment in Venture Round - Forbius

creative-destruction-lab_image

Creative Destruction Lab (CDL)

Creative Destruction Lab (CDL) investment in Series A - Forbius

Official Site Inspections

http://www.forbius.com

Host Informations
Whois Informations

Loading ...

More informations about "Forbius" on Search Engine